SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

about

Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.

P2860

Q54970083-16BC25A5-6BCC-4659-98FF-6DEB028D5FBE

P2860

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

Item

http://www.wikidata.org/entity/Q47994048

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

@en

SEOM clinical guidelines for diagnosis and treatment of glioblastoma

@nl

type

Item

label

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

@en

SEOM clinical guidelines for diagnosis and treatment of glioblastoma

@nl

prefLabel

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

@en

SEOM clinical guidelines for diagnosis and treatment of glioblastoma

@nl

P1476

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)

@en

P2093

C Carrato

http://www.w3.org/2001/XMLSchema#string

J Álvarez-Linera

http://www.w3.org/2001/XMLSchema#string

L Ley

http://www.w3.org/2001/XMLSchema#string

L M Navarro

http://www.w3.org/2001/XMLSchema#string

M A Vaz-Salgado

http://www.w3.org/2001/XMLSchema#string

M Martínez-Aguillo

http://www.w3.org/2001/XMLSchema#string

M Martínez-Garcia

http://www.w3.org/2001/XMLSchema#string

R Luque

http://www.w3.org/2001/XMLSchema#string

X Maldonado

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

P2888

s12094-017-1763-6

P304

22-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1763-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Gil-Gil

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29086250

http://www.w3.org/2001/XMLSchema#string

P932

5785619

http://www.w3.org/2001/XMLSchema#string

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

about

P2860

P2860

SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932